Raf/ERK/Nrf2 signaling pathway and MMP-7 expression involvement in the trigonelline-mediated inhibition of hepatocarcinoma cell migration

Food and Nutrition Research

Volumn 59, Issue , 2015, Pages

  Liao, Jung Chun ^a   Lee, Kun Tsung ^b   You, Bang Jau ^a   Lee, Chia Lin ^a   Chang, Wen Te ^a   Wu, Yang Chang ^a   Lee, Hong Zin ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chemotherapeutic agent; Hepatocarcinoma Hep3B cells; Migration; MMP 7; Pisum sativum; Raf ERK Nrf2 signaling pathway; Trigonelline

Indexed keywords

CATALASE; GELATINASE A; GELATINASE B; GLUTATHIONE PEROXIDASE; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ALPHA; RAF PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TRIGONELLINE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPATOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PEA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84958567964     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v59.29884     Document Type: Article

References (46)

1. Nuhu AA. Bioactive micronutrients in coffee: recent analytical approaches for characterization and quantification. ISRN Nutr 2014; 2014: 384230, doi:http://dx.doi.org/10.1155/2014/384230
2. Casal S, Oliveira MB, Alves MR, Ferreira MA. Discriminate analysis of roasted coffee varieties for trigonelline, nicotinic acid, and caffeine content. J Agric Food Chem 2000; 48: 3420-4.
3. Lang R, Yagar EF, Wahl A, Beusch A, Dunkel A, Dieminger N, et al. Quantitative studies on roast kinetics for bioactives in coffee. J Agric Food Chem 2013; 61: 12123-8.
4. Zhao HQ, Qu Y, Wang XY, Zhang HJ, Li FM, Masao H. Determination of trigonelline in Trigonella foenum-graecum by HPLC. Zhongguo Zhong Yao Za Zhi 2002; 27: 194-6.
5. Tramontano WA, Lynn DG, Evans LS. Trigonelline, nicotinic acid and nicotinamide in seedlings of Pisum sativum. Phytochemistry 1983; 22: 673-8.
6. Boettler U, Sommerfeld K, Volz N, Pahlke G, Teller N, Somoza V, et al. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J Nutr Biochem 2011; 22: 426-40.
7. Kalaska B, Piotrowski L, Leszczynska A, Michalowski B, Kramkowski K, Kaminski T, et al. Antithrombotic effects of pyridinium compounds formed from trigonelline upon coffee roasting. J Agric Food Chem 2014; 62: 2853-60.
8. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002; 12: 202-5.
9. Jang ES, Jeong SH, Lee SH, Hwang SH, Ahn SY, Lee J, et al. The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 2013; 33: 1092-9.
10. Hirakawa N, Okauchi R, Miura Y, Yagasaki K. Anti-invasive activity of niacin and trigonelline against cancer cells. Biosci Biotechnol Biochem 2005; 69: 653-8.
11. Müller M, Banning A, Brigelius-Flohé R, Kipp A. Kipp Nrf2 target genes are induced under marginal selenium-deficiency. Genes Nutr 2010; 5: 297-307.
12. Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaBinflammatory response and elicits apoptosis. Biochem Pharmacol 2008; 76: 1485-9.
13. Chen B, Zhang Y, Wang Y, Rao J, Jiang X, Xu Z. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. J Steroid Biochem Mol Biol 2014; 143C: 11-18.
14. Jo GH, Kim GY, Kim WJ, Park KY, Choi YH. Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway. Int J Oncol 2014; 45: 1497-506.
15. Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, et al. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis 2014; 35: 1872-80.
16. Sebens S, Bauer I, Geismann C, Grage-Griebenow E, Ehlers S, Kruse ML, et al. Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection. J Biol Chem 2011; 286: 40911-21.
17. Kim SK, Yang JW, Kim MR, Roh SH, Kim HG, Lee KY, et al. Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Radic Biol Med 2008; 45: 537-46.
18. Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer 2009; 45: 2219-27.
19. Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH, et al. Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas 2010; 39: 463-72.
20. Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 2010; 16: 3743-53.
21. Pi J, Bai Y, Reece JM, Williams J, Liu D, Freeman ML, et al. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic Biol Med 2007; 42: 1797-806.
22. Niture SK, Kaspar JW, Shen J, Jaiswal AK. Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 2010; 224: 37-42.
23. Banerjee P, Basu A, Datta D, Gasser M, Waaga-Gasser AM, Pal S. The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. J Biol Chem 2011; 286: 33580-90.
24. Funes JM, Henderson S, Kaufman R, Flanagan JM, Robson M, Pedley B, et al. Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival. Mol Cancer 2014; 13: 20.
25. Aməlinei C, Cəruntu ID, Bəlan RA. Biology of metalloproteinases. Rom J Morphol Embryol 2007; 48: 323-34.
26. Kostova E, Slaninka-Miceska M, Labacevski N, Jakovski K, Trojachanec J, Atanasovska E, et al. Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer. Vojnosanit Pregl 2014; 71: 52-9.
27. Mäkinen LK, Häyry V, Hagström J, Sorsa T, Passador-Santos F, Keski-Säntti H, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma. Head Neck 2014; 36: 1783-8.
28. Long ZW, Wang JL, Wang YN. Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a metaanalysis. Tumour Biol 2014; 35: 11415-26.
29. Pan H, Wang H, Zhu L, Mao L, Qiao L, Su X. The role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg 2013; 80: 363-70.
30. Shen H, Yang Y, Xia S, Rao B, Zhang J, Wang J. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment. Dis Esophagus 2014; 27: 685-92.
31. You BJ, Wu YC, Lee CL, Lee HZ. Non-homologous end joining pathway is the major route of protection against 4bhydroxywithanolide E-induced DNA damage in MCF-7 cells. Food Chem Toxicol 2014; 65: 205-12.
32. Lin CL, Chen HJ, Hou WC. Activity staining of glutathione peroxidase after electrophoresis on native and sodium dodecyl sulfate polyacrylamide gels. Electrophoresis 2002; 23: 513-16.
33. Leung HW, Kuo CL, Yang WH, Lin CH, Lee HZ. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol 2006; 534: 12-18.
34. Huang YP, Ni CH, Lu CC, Chiang JH, Yang JS, Ko YC, et al. Suppressions of migration and invasion by cantharidin in TSGH-8301 human bladder carcinoma cells through the inhibitions of matrix metalloproteinase-2/-9 signaling. Evid Based Complement Alternat Med 2013; 2013: 190281, doi:http://dx. doi.org/10.1155/2013/190281
35. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008; 29: 1235-43.
36. Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse ML, et al. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 2013; 32: 4825-35.
37. Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 2006; 22: 217-30.
38. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994; 269: 2032-40.
39. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006; 231: 20-7.
40. Yang B, Gao J, Rao Z, Zhang B, Ouyang W, Yang C. Antisense oligonucleotide targeting matrix metalloproteinase-7 (MMP-7) changes the ultrastructure of human A549 lung adenocarcinoma cells. Ultrastruct Pathol 2011; 35: 256-9.
41. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003; 22: 145-52.
42. Chuang HC, Su CY, Huang HY, Huang CC, Chien CY, Du YY, et al. Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Mod Pathol 2008; 21: 1444-50.
43. Xing XJ, Gu XH, Ma TF. Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis. Tumour Biol 2014; 35: 10515-22.
44. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 2010; 46: 226-31.
45. Chang MC, Chen CA, Chen PJ, Chiang YC, Chen YL, Mao TL, et al. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways. Biochem J 2012; 442: 293-302.
46. Tan X, Egami H, Abe M, Nozawa F, Hirota M, Ogawa M. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. J Clin Pathol 2005; 58: 1242-8.